Filing Flows › Bausch Health Companies (BHC) › Product sales revenue
Bausch Health Companies (BHC) Product sales revenue by quarter
Bausch Health Companies' Product sales revenue was $2.9B in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $2.2B (Q1 2025) to $2.9B (Q3 2026).
| Quarter | Product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.9B | +3% | +10% |
| Q2 2026 | $2.8B | +13% | +13% |
| Q1 2026 | $2.5B | -10% | +12% |
| Q4 2025 | $2.8B | +4% | — |
| Q3 2025 | $2.7B | +6% | — |
| Q2 2025 | $2.5B | +12% | — |
| Q1 2025 | $2.2B | — | — |
Q3 2026 at a glance
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bausch Health Companies' Product sales revenue?
Bausch Health Companies' Product sales revenue was $2.9B in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Bausch Health Companies' Product sales revenue changed?
Over the last 7 quarters it ranged from $2.2B (Q1 2025) to $2.9B (Q3 2026).
Q3 2026 results → · How Bausch Health Companies makes money →